TITLE

Transplantation of Induced Pluripotent Stem Cells Improves Functional Recovery in Huntington's Disease Rat Model

AUTHOR(S)
Mu, Shuhua; Wang, Jiachuan; Zhou, Guangqian; Peng, Wenda; He, Zhendan; Zhao, Zhenfu; Mo, CuiPing; Qu, Junle; Zhang, Jian
PUB. DATE
July 2014
SOURCE
PLoS ONE;Jul2014, Vol. 9 Issue 7, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
: The purpose of this study was to determine the functional recovery of the transplanted induced pluripotent stem cells in a rat model of Huntington's disease with use of 18F-FDG microPET/CT imaging. Methods: In a quinolinic acid-induced rat model of striatal degeneration, induced pluripotent stem cells were transplanted into the ipsilateral lateral ventricle ten days after the quinolinic acid injection. The response to the treatment was evaluated by serial 18F-FDG PET/CT scans and Morris water maze test. Histological analyses and Western blotting were performed six weeks after stem cell transplantation. Results: After induced pluripotent stem cells transplantation, higher 18F-FDG accumulation in the injured striatum was observed during the 4 to 6-weeks period compared with the quinolinic acid-injected group, suggesting the metabolic recovery of injured striatum. The induced pluripotent stem cells transplantation improved learning and memory function (and striatal atrophy) of the rat in six week in the comparison with the quinolinic acid-treated controls. In addition, immunohistochemical analysis demonstrated that transplanted stem cells survived and migrated into the lesioned area in striatum, and most of the stem cells expressed protein markers of neurons and glial cells. Conclusion: Our findings show that induced pluripotent stem cells can survive, differentiate to functional neurons and improve partial striatal function and metabolism after implantation in a rat Huntington's disease model.
ACCESSION #
97360421

 

Related Articles

  • All eyes on stem cells. Little, Natasha // New Scientist;2/8/2014, Vol. 221 Issue 2955, p27 

    An interview with biologist Masayo Takahashi at the Riken Center for Developmental Biology in Kobe, Japan, is presented. He discusses why the first ever human study using induced pluripotent stem (iPS) cells is such a big deal, how would treatment with iPS cells work, and dangers associated with...

  • Huntington's disease: Dancing in a dish. Zhang, Kejing; Yi, Fei; Liu, Guang-Hui; Belmonte, Juan Carlos Izpisua // Cell Research;Dec2012, Vol. 22 Issue 12, p1627 

    In a recent landmark paper, the Huntington's disease (HD) iPSC Consortium reports on the establishment and characterization of a panel of iPSC lines from HD patients, and more importantly, the successful modeling of HD in vitro. In the same issue of Cell Stem Cell, An et al. reports on the...

  • Small but Significant: Inter- and Intrapatient Variations in iPS Cell-based Disease Modeling. Sgodda, Malte; Cantz, Tobias // Molecular Therapy;Jan2013, Vol. 21 Issue 1, p5 

    The article presents a study which discusses the use of intra-patient variations in induced pluripotent stem (IPS) cells based transplants for disease modeling. The study uses disease modeling of patient specific IPS cell and reprogramming with pluripotency associated transcriptome or epigenome....

  • Life is a continuous journey of transformation? DAMLE, S. G. // Contemporary Clinical Dentistry;Jul-Sep2013, Vol. 4 Issue 3, p277 

    The author reflects on a study which directed urine stem cells to be converted into bladder type cells such as endothelial cells and smooth muscle cells. He says that the study is based on previous research on cell multipotency as well as studies that show induced pluripotent stem cells (iPSC)...

  • Advances in β cell replacement and regeneration strategies for treating diabetes. Benthuysen, Jacqueline R.; Carrano, Andrea C.; Sander, Maike // Journal of Clinical Investigation;Oct2016, Vol. 126 Issue 10, p3651 

    In the past decade, new approaches have been explored that are aimed at restoring functional β cell mass as a treatment strategy for diabetes. The two most intensely pursued strategies are β cell replacement through conversion of other cell types and β cell regeneration by enhancement...

  • Specific Reactions of Different Striatal Neuron Types in Morphology Induced by Quinolinic Acid in Rats. Feng, Qiqi; Ma, Yuxin; Mu, Shuhua; Wu, Jiajia; Chen, Si; OuYang, Lisi; Lei, Wanlong // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    Huntington's disease (HD) is a neurological degenerative disease and quinolinic acid (QA) has been used to establish HD model in animals through the mechanism of excitotoxicity. Yet the specific pathological changes and the underlying mechanisms are not fully elucidated. We aimed to reveal the...

  • Therapeutic potential of somatic cell nuclear transfer for degenerative disease caused by mitochondrial DNA mutations. Greggains, Gareth D.; Lister, Lisa M.; Tuppen, Helen A. L.; Zhang, Qi; Needham, Louise H.; Prathalingam, Nilendran; Hyslop, Louise A.; Craven, Lyndsey; Polanski, Zbigniew; Murdoch, Alison P.; Turnbull, Douglass M.; Herbert, Mary // Scientific Reports;1/24/2014, p1 

    Induced pluripotent stem cells (iPSCs) hold much promise in the quest for personalised cell therapies. However, the persistence of founder cell mitochondrial DNA (mtDNA) mutations limits the potential of iPSCs in the development of treatments for mtDNA disease. This problem may be overcome by...

  • Comparison of Human Primary with Human iPS Cell-Derived Dopaminergic Neuron Grafts in the Rat Model for Parkinson's Disease. Peng, Su-Ping; Copray, Sjef // Stem Cell Reviews & Reports;Feb2016, Vol. 12 Issue 1, p105 

    Neuronal degeneration within the substantia nigra and the loss of the dopaminergic nigro-striatal pathway are the major hallmarks of Parkinson's disease (PD). Grafts of foetal ventral mesencephalic (VM) dopaminergic (DA) neurons into the striatum have been shown to be able to restore striatal...

  • Differential Requirement for Utrophin in the Induced Pluripotent Stem Cell Correction of Muscle versus Fat in Muscular Dystrophy Mice. Beck, Amanda J.; Vitale, Joseph M.; Qingshi Zhao; Schneider, Joel S.; Corey Chang; Altaf, Aneela; Michaels, Jennifer; Bhaumik, Mantu; Grange, Robert; Fraidenraich, Diego // PLoS ONE;2011, Vol. 6 Issue 5, p1 

    Duchenne muscular dystrophy (DMD) is an incurable degenerative muscle disorder. We injected WT mouse induced pluripotent stem cells (iPSCs) into mdx and mdx:utrophin mutant blastocysts, which are predisposed to develop DMD with an increasing degree of severity (mdx ,,, mdx:utrophin). In mdx...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics